🇺🇸 FDA
Patent

US 9181530

Infectious hepatitis E virus genotype 3 recombinants

granted A61KA61K39/00A61P

Quick answer

US patent 9181530 (Infectious hepatitis E virus genotype 3 recombinants) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K39/00, A61P, A61P1/16, A61P31/14